Miach Orthopaedics, Inc.

Miach Orthopaedics is a privately held company headquartered in Westborough, Massachusetts, dedicated to developing bio-engineered surgical implants for connective tissue restoration. Their flagship product is the Bridge-Enhanced® ACL Restoration (BEAR®) Implant, a paradigm shift in ACL tear treatment, moving from reconstruction to restoration. The BEAR Implant facilitates healing of the torn ACL by acting as a bridge between the torn ends, allowing the body to heal the ligament back together while maintaining its original attachments. The BEAR Implant is absorbed by the body as the ACL heals.

Miach Orthopaedics was founded by Dr. Martha Murray, a professor of orthopaedic surgery at Harvard Medical School and an orthopaedic surgeon in the Sports Medicine Division at Boston Children's Hospital. The company has received significant funding from investors including Amzak Health Investors LLC, DSM Venturing, and the NFL Players Association, enabling them to conduct extensive clinical trials and secure De Novo approval from the FDA for the BEAR Implant. The BEAR Implant is currently commercially available in the United States and has been used to treat hundreds of patients.

Miach Orthopaedics is a privately held company dedicated to developing bio-engineered surgical implants for connective tissue restoration. Their primary focus is on the Bridge-Enhanced® ACL Restoration (BEAR®) Implant, a groundbreaking technology that aims to change the standard of care for ACL tears from reconstruction to restoration, enabling the body to heal its own torn ligament. This revolutionary approach offers a less invasive and potentially more effective treatment option for patients, ultimately restoring natural anatomy and function of the knee.

Miach Orthopaedics fosters a culture of innovation and collaboration, driven by a shared passion for improving patient outcomes. The company values entrepreneurial spirit and a drive for excellence, attracting individuals who are dedicated to pushing the boundaries of medical technology. This is evident in their team's commitment to developing the BEAR implant, a groundbreaking solution for ACL injuries. They cultivate a collaborative environment, drawing upon diverse perspectives and expertise to achieve their goals, ensuring a high level of dedication to patients and a commitment to making a real difference in the field of orthopedic surgery.